Lilly Sees More Dealmaking as GLP-1 Wins Expand Market
Eli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
Performance variance reflects market swings and fund mechanics. This intro highlights how to interpret variation across periods.
27,234 articlesEli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
Investors are abuzz over SpaceX’s potential IPO, yet a new danger lurks: leveraged ETFs designed to double daily move...
As the Iran conflict intensified in early 2026, gold failed to rally as expected. A hypothetical $10,000 in gold woul...
May delivered a sharp reversal for Bitcoin ETFs, with the biggest weekly outflows since January as risk-off trading s...
As AI workloads surge, memory becomes a key battleground. This guide breaks down Micron and Sandisk fundamentals, gro...
As AI and cloud demand shape the tech landscape in early 2026, investors debate whether broad exposure through XLK or...
Apple abandons the stalemate of building bigger AI models. In a bold pivot, the company opens iOS 27 to rival assista...
In a market thirsting for the next big tech winner, the steady power of dividend growth often goes unseen. This artic...
Alphabet's plan to issue new stock could dilute existing holders. This deep dive explains what that means for investo...
Oracle is set to report its June quarter as AI demand tests the cloud backbone. Backlog and RPO could reveal real app...
As Mink (INKT) closes 2025, investors want clarity on growth, margins, and cash generation. This analysis breaks down...
A top analyst’s optimistic view on Micron highlights AI-driven memory demand and a potential upcycle in DRAM and NAND...